AAAAAA

   
Results: 1-8 |
Results: 8
SUBCUTANEOUS INTERLEUKIN-2 AS INITIAL THERAPY FOR PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL OF CANCER AND LEUKEMIA GROUP-B
Authors: CLAMON G HERNDON J AKERLEY W GREEN M
Citation: G. Clamon et al., SUBCUTANEOUS INTERLEUKIN-2 AS INITIAL THERAPY FOR PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL OF CANCER AND LEUKEMIA GROUP-B, Lung cancer, 19(1), 1998, pp. 25-29
RANDOMIZED TRIAL OF VINORELBINE COMPARED WITH FLUOROURACIL PLUS LEUCOVORIN IN PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER
Authors: CRAWFORD J OROURKE M SCHILLER JH SPIRIDONITIS CH YANOVICH S OZER H LANGLEBEN A HUTCHINS L KOLETSKY A CLAMON G BURMAN S WHITE R HOHNEKER J
Citation: J. Crawford et al., RANDOMIZED TRIAL OF VINORELBINE COMPARED WITH FLUOROURACIL PLUS LEUCOVORIN IN PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2774-2784
A PHASE I II TRIAL OF ETOPOSIDE AND CISPLATIN IN EXTENSIVE SMALL-CELLLUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY/
Authors: MITCHELL EP PERRY MC LUIKART SD CIRRINCIONE CT VANECHO DA HERNDON JE MAURER LH CLAMON G GREEN MR
Citation: Ep. Mitchell et al., A PHASE I II TRIAL OF ETOPOSIDE AND CISPLATIN IN EXTENSIVE SMALL-CELLLUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY/, Lung cancer, 15(2), 1996, pp. 215-223
A RANDOMIZED PHASE-II STUDY OF IFOSFAMIDE MESNA/CISPLATIN PLUS G-CSF OR ETOPOSIDE/CISPLATIN PLUS G-CSF IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY/
Authors: GRAZIANO SL VALONE FH HERNDON JE CRAWFORD J RICHARDS F REGE VB CLAMON G GREEN MR
Citation: Sl. Graziano et al., A RANDOMIZED PHASE-II STUDY OF IFOSFAMIDE MESNA/CISPLATIN PLUS G-CSF OR ETOPOSIDE/CISPLATIN PLUS G-CSF IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY/, Lung cancer, 14(2-3), 1996, pp. 315-329
ETOPOSIDE (VP-16) AND CISPLATIN AT MAXIMUM TOLERATED DOSE IN NON-SMALL-CELL LUNG-CARCINOMA - A CANCER AND LEUKEMIA GROUP-B STUDY
Authors: MUSCATO JJ CIRRINCIONE C CLAMON G PERRY MC OMURA G BERKOWITZ I REID T HERNDON JE GREEN MR
Citation: Jj. Muscato et al., ETOPOSIDE (VP-16) AND CISPLATIN AT MAXIMUM TOLERATED DOSE IN NON-SMALL-CELL LUNG-CARCINOMA - A CANCER AND LEUKEMIA GROUP-B STUDY, Lung cancer, 13(3), 1995, pp. 285-294
A FEASIBILITY STUDY OF EXTENDED CHEMOTHERAPY FOR LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER - A PHASE-II TRIAL OF CANCER AND LEUKEMIA GROUP-B
Authors: CLAMON G HERNDON J EATON W ROSENMAN J MAUER LH COOPER MR GREEN MR
Citation: G. Clamon et al., A FEASIBILITY STUDY OF EXTENDED CHEMOTHERAPY FOR LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER - A PHASE-II TRIAL OF CANCER AND LEUKEMIA GROUP-B, Cancer investigation, 12(3), 1994, pp. 273-282
CLINICAL-PHARMACOLOGY OF HIGH-DOSE LOVASTATIN
Authors: HOHL RJ LEWIS K CLAMON G KNAPP H
Citation: Rj. Hohl et al., CLINICAL-PHARMACOLOGY OF HIGH-DOSE LOVASTATIN, Clinical research, 42(3), 1994, pp. 10000394-10000394
RELATIONSHIP BETWEEN TUMOR AREA, TUMOR VOLUME, AND CRITERIA OF RESPONSE IN CLINICAL-TRIALS
Authors: CLAMON G CLAMON L
Citation: G. Clamon et L. Clamon, RELATIONSHIP BETWEEN TUMOR AREA, TUMOR VOLUME, AND CRITERIA OF RESPONSE IN CLINICAL-TRIALS, Journal of clinical oncology, 11(5), 1993, pp. 1005-1005
Risultati: 1-8 |